Cefuroxime Axetil
19 NDCs across 6 manufacturers|19 Generic,0 Brand
Cefuroxime Axetil is used to treat infectious bone diseases, escherichia coli infections, gonorrhea, haemophilus infections, impetigo and klebsiella infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 28, 1987, and the first generic was approved Feb 15, 2002. FDA's Orange Book lists 11 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $17 million on Cefuroxime Axetil across 1.1 million claims for 921,000 beneficiaries.
Cefuroxime Axetil is available as 19 NDCs from 6 manufacturers (19 generic, 0 brand), with NADAC prices from $0.29 to $0.38 per EA — a 29% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
19
19G / 0B
Manufacturers
6
competing in market
Price Spread
$0.29 – $0.38
per EA
7d Activity
avg -0.7% WoW · of 19 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
6 manufacturers producing CEFUROXIME AXETIL(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CEFUROXIME AXETIL 500 MG TAB | $0.3786 per EA | +0.20% |
CEFUROXIME AXETIL 500 MG TAB | $0.3786 per EA | +0.20% |
CEFUROXIME AXETIL 500 MG TAB | $0.3786 per EA | +0.20% |
CEFUROXIME AXETIL 500 MG TAB | $0.3786 per EA | +0.20% |
CEFUROXIME AXETIL 500 MG TAB | $0.3786 per EA | +0.20% |
CEFUROXIME AXETIL 500 MG TAB | $0.3786 per EA | +0.20% |
CEFUROXIME AXETIL 500 MG TAB | $0.3786 per EA | +0.20% |
CEFUROXIME AXETIL 500 MG TAB | $0.3786 per EA | +0.20% |
CEFUROXIME AXETIL 500 MG TAB | $0.3786 per EA | +0.20% |
CEFUROXIME AXETIL 250 MG TAB | $0.2925 per EA | -1.48% |
CEFUROXIME AXETIL 250 MG TAB | $0.2925 per EA | -1.48% |
CEFUROXIME AXETIL 250 MG TAB | $0.2925 per EA | -1.48% |
CEFUROXIME AXETIL 250 MG TAB | $0.2925 per EA | -1.48% |
CEFUROXIME AXETIL 250 MG TAB | $0.2925 per EA | -1.48% |
CEFUROXIME AXETIL 250 MG TAB | $0.2925 per EA | -1.48% |
CEFUROXIME AXETIL 250 MG TAB | $0.2925 per EA | -1.48% |
CEFUROXIME AXETIL 250 MG TAB | $0.2925 per EA | -1.48% |
CEFUROXIME AXETIL 250 MG TAB | $0.2925 per EA | -1.48% |
CEFUROXIME AXETIL 250 MG TAB | $0.2925 per EA | -1.48% |
Frequently Asked Questions
What is Cefuroxime Axetil used to treat?
Cefuroxime Axetil is used to treat infectious bone diseases, escherichia coli infections, gonorrhea, haemophilus infections, impetigo and klebsiella infections, per the National Library of Medicine's MED-RT classification.
When did Cefuroxime Axetil become available as a generic?
FDA approved the first generic Cefuroxime Axetil (ANDA) on Feb 15, 2002. The Orange Book currently lists 11 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Cefuroxime Axetil?
In 2024, Medicare Part D spent $17 million on Cefuroxime Axetil across 1.1 million claims for 921,000 beneficiaries.
How many Cefuroxime Axetil products are on the market?
The Cefuroxime Axetil drug market contains 19 NDCs from 6 manufacturers — 19 generic and 0 brand products.
What is the price range for Cefuroxime Axetil?
NADAC reference prices for Cefuroxime Axetil range from $0.2925 to $0.3786 per EA — a 29% difference between cheapest and most expensive.
Which manufacturers make Cefuroxime Axetil?
6 manufacturers list Cefuroxime Axetil in NADAC. Ranked by number of NDCs, the largest are NorthStar Rx LLC (4), Rising Pharma Holdings Inc. (4), Aurobindo Pharma Limited (4), Ascend Laboratories, LLC (4), American Health Packaging (2).
How has the price of Cefuroxime Axetil changed recently?
Over the past 7 days, 9 Cefuroxime Axetil NDCs rose and 10 fell, with a market-wide average change of -0.7%.